Klingman & Associates, LLC Boston Scientific Corp Transaction History
Klingman & Associates, LLC
- $1.97 Billion
- Q3 2025
A detailed history of Klingman & Associates, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Klingman & Associates, LLC holds 2,241 shares of BSX stock, worth $230,128. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,241
Previous 1,914
17.08%
Holding current value
$230,128
Previous $205,000
6.34%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding BSX
# of Institutions
1,949Shares Held
1.26BCall Options Held
10.8MPut Options Held
8.94M-
Vanguard Group Inc Valley Forge, PA138MShares$14.2 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY126MShares$13 Billion0.22% of portfolio
-
State Street Corp Boston, MA64.9MShares$6.67 Billion0.23% of portfolio
-
Bank Of America Corp Charlotte, NC33.9MShares$3.48 Billion0.23% of portfolio
-
Primecap Management CO Pasadena, CA33.1MShares$3.4 Billion2.56% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $147B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...